Literature DB >> 30114626

Dysregulation of long non-coding RNA profile in peripheral blood of multiple sclerosis patients.

Romina Dastmalchi1, Soudeh Ghafouri-Fard1, Mir Davood Omrani2, Mehrdokht Mazdeh3, Arezou Sayad4, Mohammad Taheri5.   

Abstract

Multiple sclerosis (MS) is a chronic autoimmune disorder in which dysregulation or aberrant expressions of several immune-related genes have been noted. More recently, the participation of long non-coding RNAs (lncRNAs) in regulation of immune responses has been highlighted. In the present study, we evaluated expression levels of three lncRNAs named Nuclear Paraspeckle Assembly Transcript 1 (NEAT1), P21 associated ncRNA DNA damage activated (PANDA) and Taurine-up-regulated gene 1 (TUG1) in peripheral blood of 50 relapsing-remitting MS patients and 50 matched healthy subjects. All three lncRNAs have been significantly over-expressed in MS patients compared with healthy subjects. In addition, significant correlations were found between expression levels of these three lncRNAs in the patients group. NEAT1 expression was inversely correlated with age at onset and disease duration in female patients. Moreover, TUG1 expression was inversely correlated with disease duration in female patients. The present study provides further evidences for the role of lncRNAs in pathogenesis of MS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Multiple sclerosis; NEAT1; PANDA; TUG1

Mesh:

Substances:

Year:  2018        PMID: 30114626     DOI: 10.1016/j.msard.2018.07.044

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  15 in total

Review 1.  Role of long non-coding RNAs (LncRNAs) in multiple sclerosis: a brief review.

Authors:  Eskandar Taghizadeh; Forough Taheri; Mohammad Mahdi Samadian; Mohammad Soudyab; Abbas Abi; Seyed Mohammad Gheibi Hayat
Journal:  Neurol Sci       Date:  2020-04-30       Impact factor: 3.307

2.  Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod.

Authors:  Mohammad Mahdi Eftekharian; Alireza Komaki; Mehrdokht Mazdeh; Shahram Arsang-Jang; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2019-03-21       Impact factor: 3.444

3.  The Putative Association of TOB1-AS1 Long Non-coding RNA with Immune Tolerance: A Study on Multiple Sclerosis Patients.

Authors:  Reyhaneh Dehghanzad; Majid Pahlevan Kakhki; Asieh Alikhah; Mohammad Ali Sahraian; Mehrdad Behmanesh
Journal:  Neuromolecular Med       Date:  2019-09-03       Impact factor: 3.843

Review 4.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

5.  Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?

Authors:  Shahram Torkamandi; Shima Bahrami; Tahereh Ghorashi; Mohammad Dehani; Hadi Bayat; Seyyed Mohamad Hoseini; Somaye Rezaei; Mohsen Soosanabadi
Journal:  Genes Immun       Date:  2021-11-15       Impact factor: 2.676

6.  Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome.

Authors:  Maomao Zhang; Yang Zheng; Yong Sun; Shuang Li; Liangqi Chen; Xiangyuan Jin; Xinyu Hou; Xianglan Liu; Qi Chen; Jing Li; Mingyang Liu; Xianghui Zheng; Yongxiang Zhang; Jian Wu; Bo Yu
Journal:  Theranostics       Date:  2019-05-24       Impact factor: 11.556

7.  LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis.

Authors:  Olfat G Shaker; Rania H Mahmoud; Omayma O Abdelaleem; Enas G Ibrahem; Abdelrahmaan A Mohamed; Othman M Zaki; Noha K Abdelghaffar; Tarek I Ahmed; Nada F Hemeda; Naglaa A Ahmed; Dina F Mansour
Journal:  Biosci Rep       Date:  2019-01-15       Impact factor: 3.840

8.  Evaluation of The Expression Levels of Three Long Non-Coding RNAs in Multiple Sclerosis.

Authors:  Afshin Moradi; Mahdis Rahimi Naiini; Nasrin Yazdanpanahi; Hossein Tabatabaeian; Fariba Nabatchian; Masoud Baghi; Mansoureh Azadeh; Kamran Ghaedi
Journal:  Cell J       Date:  2019-10-14       Impact factor: 2.479

Review 9.  What do we know about the role of lncRNAs in multiple sclerosis?

Authors:  Viviana Nociti; Massimo Santoro
Journal:  Neural Regen Res       Date:  2021-09       Impact factor: 5.135

10.  Identification of New Potential LncRNA Biomarkers in Hirschsprung Disease.

Authors:  Ana Torroglosa; Leticia Villalba-Benito; Raquel María Fernández; Berta Luzón-Toro; María José Moya-Jiménez; Guillermo Antiñolo; Salud Borrego
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.